Uncoupling protein-2 (UCP2) is an inner-mitochondrial membrane proton carrier that uncouples ATP synthesis. The aim of this study was to determine if UCP2 plays a role in survival of adult rat cardiac myocytes. We first studied the effects of UCP2 overexpression in vitro.
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Introduction
The heart is a high-energy demand organ in continuous need for ATP. Uncoupling proteins from the mitochondrial carrier family are capable of uncoupling ATP synthesis by dissipating the proton gradient, resulting in the generation of heat and decreased ATP production. Uncoupling protein-2 was discovered in 1997 and found in a variety of tissues (10). Since then, over seven hundred papers have been published on UCP2. A number of different functions have been assigned to this protein. It was suggested that UCP2 can mediate proton leak (23) , negatively regulate reactive oxygen species (ROS) production (2), regulate insulin metabolism (50) , modulate mitochondrial Ca 2+ uptake (46) , and modulate apoptosis, either by promoting cell death (29, 44) or cell survival (24, 27, 45) . There are numerous contradictory in vitro and in vivo studies in literature with quite divergent results from different laboratories recently reviewed by MN Sack (40) regarding the role of UCP2 and its distribution within the body, and even species specific
variations. Other reviews also analyze existing controversy and show evidence for and against several suggested functions, as well as a distribution of mRNA and protein among different organs (4, 22, 33) . Overall, some studies show a protective role of UCP2 while others demonstrate the opposite effect.
The loss of cardiomyocytes through apoptosis has been shown to contribute to numerous cardiovascular disorders such as progressive left ventricular dysfunction in heart failure, ischemia reperfusion, and dilated cardiomyopathy. Various cellular factors and signaling pathways that are known to promote cell survival or cell death are of great interest as possible therapeutic targets.
The aim of the present study was, therefore, to investigate the effects of UCP2 overexpression in vitro on cell viability in cardiomyocytes under normal conditions, and under hypoxia/reoxygenation -a clinically relevant model of several heart disease states. We also analyzed UCP2 mRNA expression level in vivo in the heart in the Dahl salt-sensitive rat model of heart failure. The present study describes a significant deleterious effect of UCP2 overexpression in vitro on adult rat cardiomyocyte survival in a hypoxia/reoxygenation setting, and reports an accumulation of prodeath protein BNIP3 (Bcl-2 and nineteen-kDa interacting protein-3) in UCP2 overexpressing adult rat cardiomyocytes. In vivo results show that UCP2 is upregulated along with BNIP3 and suggest its deleterious effect in heart failure.
Materials and Methods
Primary culture of adult cardiac myocytes and induction of apoptosis by hypoxia/reoxygenation
Adult rat cardiac myocyte cultures were obtained from the hearts of female SpragueDawley rats using techniques consistent with a previously published protocol (19, 20) . Briefly, the hearts were excised and perfused for 45-60 min with 0.3% collagenase (Worthington Biochemical Corp). Cell death was induced by hypoxia (applied for 9 hrs) followed by reoxygenation (18 hrs) as previously described (19, 20) .
Generation of recombinant adenovirus
Mouse UCP2 cDNA was cloned into pShuttle-CMV vector (Invitrogen Inc.). Recombinant adenovirus expressing UCP2 (AdUCP2) was generated using AdEasy Adenoviral Vector System Luciferase activity was measured using a luminometer (TD-20/20 Turner Design). Protein content was also measured using the collected supernatant.
Cell Survival and cell death analysis
Cell survival in vitro was measured by the widely used MTT assay according to manufacturer instructions (Sigma, St. Louis, MO). Briefly, cells were treated with MTT for 3 hrs. Formed formazan crystals were dissolved with MTT solvent, while plates were agitated on shaker for 30 min. Absorbance was measured as a ratio of a wavelength of 570 nm, to 690 nm. MTT assay can no longer be considered strictly a mitochondrial assay, since MTT reduction is associated not only with mitochondria, but also with the cytoplasm and with non-mitochondrial membranes (3).
Western blotting
UCP2 (Santa-Cruz), BNIP3 (Sigma), GAPDH (RDI) and Cox IV (Cell Signaling) protein levels were examined in cell or heart tissue lysates using Western blotting. Samples were run on 15% SDS gels and transferred to PVDF membranes. Antibodies were diluted as follows: UCP2
(1:100), BNIP3 (1:1000), GAPDH (1:5000), Cox IV (1:1000).
Northern Blotting
Total RNA was extracted from rat hearts using TRIzol Reagent (Invitrogen). A 15 Lg aliquot of total RNA was electrophoresed in 1.3% denaturing formaldehyde agarose gels and blotted onto Hybond N (Amersham). Membranes were hybridized with UCP2 (whole mouse cDNA fragment), atrial natriuretic peptide (ANP) and GAPDH probes labeled with [ -32 P]CTP (Random primers DNA labeling system, Invitrogen). Details of the probes were previously described (28) .
Dahl salt sensitive rat heart failure model
DSS rat heart failure model was generated as described previously (19, 20) . Briefly Female DSS rats (Harlan Sprague Dawley, Inc.) were fed a HS diet (6% NaCl) beginning at 6 wk of age.
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Only rats that showed overt clinical evidence of heart failure were included in the study with an average age of 20 week. Control age-matched rats were fed normal chow.
Statistical analysis
All data were expressed as mean ±SEM. Between groups and among groups comparisons were conducted with unpaired Student t tests and ANOVAs, respectively. Probability (p) values of <0.05 were considered significant.
Results
UCP2 overexpression leads to ATP depletion, acidosis, but does not affect cardiomyocyte viability at baseline
First, in order to study specific effects of UCP2, we designed siRNA against UCP2 to block UCP2 expression at both mRNA and protein levels. To deliver siRNA into cardiomyocytes, we constructed three separate siRNA adenoviruses (AdsiRNA) differing only in cDNA sequences.
While all constructed AdsiRNAs effectively blocked adenovirus mediated UCP2 overexpression at mRNA and proteins levels in H9c2 cells and cardiomyocytes, respectively ( Fig. 1) , construct 3 (siUCP2 3) with the sequence 5'-GCCACTTCACTTCTGCCTTCG-3' was found to be most efficient and therefore used for all subsequent studies. Overexpression of UCP2 did not affect mitochondria level in cardiomyocytes, since Cox IV protein level remained unchanged (Fig. 1B) .
To investigate the effects of UCP2 overexpression specifically in adult cardiomyocytes at baseline, we initially focused on the protein's uncoupling abilities. One of the suggested functions of UCP2 is the regulation of ATP biosynthesis. Consistent with the findings of others showing that UCP2 leads to ATP depletion in various cell types (43, 44) , an ATP determination assay revealed
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Copyright Information H-01409-2006/R2-8 that ATP level was down significantly in cardiomyocytes after UCP2 gene transfer ( Fig. 2A) . ATP depletion observed in UCP2 overexpressing cardiomyocytes was rescued by simultaneous infection with AdsiRNA, while AdsiRNA alone did not affect ATP content. During the course of experiments using UCP2 adenoviral transfer, we observed that the pH of extracellular medium with the cardiomyocytes overexpressing UCP2 was shifted into acidic range, and while AdsiRNA prevented this pH shift, AdsiRNA alone did not affect it (Fig. 2B) .
We then assessed whether UCP2 overexpression, or depletion, has an effect on cardiomyocyte survival. At baseline, there was no significant difference in cell survival between cardiomyocytes infected with AdUCP2, or AdsiUCP2, compared to the LacZ control (AdLacZ) (Fig. 2C) . A significant drop of ATP level did not seem to affect cardiomyocyte survival at baseline during the period of experiments, although it is very likely that there may be long-term consequences of severe ATP depletion. These data are in agreement with other findings showing that complete loss of cell ATP in the case of anaerobic cold storage of cardiomyocytes did not interfere with the ability of cells to restore normal baseline function under the appropriate rewarming conditions (15) . Thus, UCP2 overexpression in adult rat cardiomyocytes leads to ATP depletion and the development of acidosis, but does not affect cell survival at base line. UCP2 depletion did not have a significant effect in cell survival.
UCP2 overexpression results in increased cell death after hypoxia/reoxygenation
The next set of experiments was carried out to determine whether UCP2 overexpression, or depletion, has a protective or deleterious effect on cardiomyocytes under stress conditions such as hypoxia/reoxygenation. Hypoxia causes a switch from oxidative to glycolytic energy generation, with increased glucose consumption, lactic acid production, and lower pH (9, 34, 48). Impaired
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Copyright Information H-01409-2006/R2-9 mitochondrial ATP formation is the key stress of anoxic and ischemic injury, and necrotic cell death after ischemia/reperfusion is directly linked to ATP depletion. When cardiomyocytes were challenged with hypoxia/reoxygenation, cells overexpressing UCP2 were most affected and survived 38% less than control cardiomyocytes infected with LacZ adenovirus. Moreover, siRNA adenovirus against UCP2 successfully blocked this effect, and rescued cardiomyocytes (Fig. 3) .
Compared to the control, siRNA alone did not have a significant effect on cell survival in response to hypoxia/reoxygenation. Thus, these experiments have demonstrated that UCP2 overexpression in cardiomyocytes leads to cell death under hypoxia/reoxygenation conditions.
BNIP3 is upregulated in vitro
Next, we examined possible molecular mechanisms that may be involved in UCP2 and hypoxia mediated cell death. It has been shown that pro-death member of BH-3 only subfamily of Bcl-2 proteins, BNIP3, is a key regulator of cell death of ventricular myocytes during hypoxia (37) . BNIP3 is implicated in the control of both apoptotic and necrotic cell death, as well as in guarding mitochondrial integrity. Hypoxia alone induces BNIP3, but BNIP3 requires activation, such as acidosis, to trigger death program (13). Acidic pH also leads to BNIP3 accumulation and increases half-life of BNIP3 dimers and monomers (11). BNIP3 activates death program in cardiac myocytes when hypoxia coincides with acidosis (11, 13, 37). In this regard, we focused on BNIP3 and found that BNIP3 protein level, as expected, was upregulated in cardiomyocytes subjected to hypoxia/reoxygenation (Fig. 4A) . In addition, UCP2 overexpression alone in cardiomyocytes resulted in upregulation of BNIP3 protein level. When cardiomyocytes were coinfected with AdsiRNA against UCP2, BNIP3 increase was effectively blocked (Fig. 4B) . These results are concordant with our cell survival data, as well as with known mechanisms of BNIP3 is not yet compromised, but BNIP3 activation may trigger cell death. Indeed, when cells were challenged with apoptotic stimuli, such as hypoxia/reoxygenation, they survived significantly less than control cardiomyocytes. Simultaneous infection of cardiomyocytes with AdsiRNA against UCP2 was able to rescue loss of cells to a level comparable to control group under hypoxia/reoxygenation.
Upregulation of both UCP2 and BNIP3 are associated with heart failure in DSS rats
To analyze differential UCP2 expression in vivo we used the Dahl salt-sensitive rat model of heart failure (20) . Rats were maintained on a high-salt diet and developed either stroke or progressive heart failure between 14 and 18 wk or 19 and 21 wk, respectively. All high-salt diet rats died by 21-23 wk, and only rats that showed overt clinical evidence of heart failure were included in the study with an average age of 20 wk (20) . We have shown previously using the gene chip array in this model, that among genes known to be expressed in heart failure, including biomarker ANF, there was a significant increase in UCP2 mRNA expression level (21) . To confirm this data, we performed Northern blot analysis. RNA was isolated from the hearts of an independent group of rats to ensure that different animals were used for the Northern blot analysis than for the microarray. Northern blot analysis confirmed that UCP2 mRNA level was significantly upregulated in failed hearts (approximately three fold) as was ANF (Fig. 5A,B) .
Next, we checked for BNIP3 in this model and found an increase in BNIP3 protein expression level in heart failure (Fig. 5C,D) . Thus, we have found that UCP2 level is upregulated in the heart failure in DSS rats, and that it coincides with increased BNIP3 expression.
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Discussion
In this study, we showed that the overexpression of UCP2 in adult cardiomyocytes does not affect cell survival at baseline, but leads to significant ATP depletion, acidosis, and accumulation of pro-death protein BNIP3. Consequently, when cardiomyocytes overexpressing UCP2 were challenged with hypoxia/reoxygenation, they survived significantly less then control cells. Our results indicate that UCP2 overexpression has a deleterious effect on cell survival and, for the first time, show that UCP2 overexpression affects BNIP3. Controversial data, however, exists in the literature concerning the role of UCP2, as well as its protein expression level. In vivo low expression of UCP2 contrasts with a high UCP2 mRNA level, and induction of UCP2 expression occurs without change in mRNA level, demonstrating a robust translational control (17). Several studies have shown the presence of the protein in the rat and human heart (27, 30, 32) , while others do not observe UCP2 in rat or mouse heart (2, 38) . Results may vary due to a variety of reasons, such as species specific variations, the quality of antibodies used, possible cross-reactivity with other UCP2 isoforms, limitations in detection systems, or intrinsic protein properties such as stability and a very short half-life, approximately 30 min (39). Further clarification of this issue is still required.
Currently exact physiological role of UCP2 remains unknown and this field is quite controversial. Some studies show that UCP2 overexpression can be beneficial for the cells (24, 45) , notably in the protection against reactive oxygen species in neuronal tissues (16, 26) . In contrast, other studies support our findings and demonstrate that UCP2 overexpression can cause cell death (29, 44). One should keep in mind that any overexpression system could potentially produce artificial biological phenomenon. To rule out possible artificial outcomes of UCP2 overexpression which may result from insertion of this protein into inner mitochondrial control to confirm specificity of the observed effects (29). Loss of function studies also yields quite divergent results. Simultaneous analysis of the depletion of UCP2 and UCP3 isoforms reveals deleterious effect of UCP2 depletion in particular (27) , while in animal models, UCP2 deficiency resulted in increased resistance to cerebral ischemia with a significantly reduced infarct size in the brain of UCP2 knockout mice (7). Our findings show that UCP2 depletion in cardiomyocytes did not have a significant effect on cell survival.
There are several in vitro and in vivo evidences that demonstrate that UCP2 upregulation may be deleterious, while downregulation may be beneficial. Increased UCP2 expression in primary cultured mesencephalic cells markedly enhanced necrosis in response to cyanide exposure (36) and led to a reduction in a number of hypocretin neurons in mice (6) . In cortical cells treated with cyanide, transfection with UCP2 switched the death mode from apoptosis to necrosis while UCP2 RNA interference and a dominant-negative mutant blocked the necrotic response (25) .
Also, an increase in UCP2 expression correlated with parenchymal necrosis and the severity of symptoms in models of acute experimental pancreatitis in rats and in mice (41) . Furthermore, in mice with a spontaneous mutation in the leptin gene, protection against ischemia-reperfusion injury by treatment with cerulenin, an inhibitor of protein acetylation, was associated with a decrease in UCP2 expression and an increase in ATP (5) . From these studies, it would appear that UCP2 can function either as a death or survival factor, depending on the initiation stimulus and death pathway executed.
Our in vivo observation that UCP2 is upregulated in DSS rat heart failure model, leads to a suggestion that UCP2 may play an important role in cardiomyocyte survival by affecting energy homeostasis. This is supported by our in vitro data showing an inverse relationship between UCP2 Page 12 of 29
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H-01409-2006/R2-13 and ATP level. In failing hearts, there is an increase in energy demand, and maintaining a high ATP supply is critically important for maintaining cardiac performance. In the failing myocardium, ATP level has been shown to progressively decrease to about 70% to 75% of normal values (18, 42), while the level of UCP2 has been shown to be increased (32) . In fact, the adverse role of UCP2 in the heart is also supported by various animal models of heart failure. In a rat model of aortic regurgitation, UCP2 mRNA level was upregulated, while the creatine phosphate content is significantly decreased (35) . In the same rat model, treatment with ACE inhibitor perindopril improved cardiac performance and myocardial energy efficiency, but also suppressed UCP2 overexpression, lending support to the hypothesis that overexpression of UCP2 may alter energy efficiency in the progression of heart failure (31) . Increased UCP2 expression is also found in GsR, S 1 AR, S 2 AR or protein kinase A-induced cardiomyopathy (12), as well as in pathological hypertrophy resulting from prolonged thyroid hormone treatment (8).
Concomitant with ATP depletion and acidosis, UCP2 overexpression in adult cardiomyocytes also led to the upregulation of BNIP3. It is known that acidosis is further exacerbated when ATP levels begin to decline (1, 34) . BNIP3 protein is induced by hypoxia and accumulates more rapidly under acidic pH (13). Acidosis may provide a "death" signal that activates BNIP3 in cardiac myocytes (14, 49) . Low pH activates pro-apoptotic functions of BNIP3 by stimulating its intracellular translocation and integration into mitochondrial membranes, where BNIP3 stimulates mitochondrial permeability transition pore opening. This process is an integral part of the cardiac myocyte death pathway (47, 49) and is referred to as an atypical form of cell death with features of both apoptosis and necrosis (49) . These data support our finding that UCP2 overexpression leads to significant cell death in cardiomyocytes challenged with hypoxia/reoxygenation via acidosis and BNIP3. In vivo, significant increase in BNIP3 expression 
